A beta-peptides enhance vasoconstriction in cerebral circulation.
about
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysisCerebrovascular disease in ageing and Alzheimer's diseaseThe pericyte: a forgotten cell type with important implications for Alzheimer's disease?The pathobiology of vascular dementiaImpaired Aβ clearance: a potential link between atherosclerosis and Alzheimer's diseaseMn porphyrin-based SOD mimic, MnTnHex-2-PyP(5+), and non-SOD mimic, MnTBAP(3-), suppressed rat spinal cord ischemia/reperfusion injury via NF-κB pathwaysAmyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent mannerPioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-β and cerebrovascular pathologyNox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein.Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease.Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice.Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.Abeta-induced vascular oxidative stress and attenuation of functional hyperemia in mouse somatosensory cortex.Hypertension, cerebrovascular impairment, and cognitive decline in aged AβPP/PS1 miceSoluble amyloid-beta, effect on cerebral arteriolar regulation and vascular cellsVascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.Cerebral amyloid angiopathy impact on endothelium.Rational design of superoxide dismutase (SOD) mimics: the evaluation of the therapeutic potential of new cationic Mn porphyrins with linear and cyclic substituents.Age-dependent neurovascular dysfunction and damage in a mouse model of cerebral amyloid angiopathy.P2Y receptors in Alzheimer's disease.Hypertension and cognitive functionDifferential effect of amyloid β on the cytochrome P450 epoxygenase activity in rat brainCapillary dysfunction: its detection and causative role in dementias and strokeNeurovascular and neurometabolic derailment in aging and Alzheimer's disease.Synaptic protein levels altered in vascular dementiaInterstitial pericytes decrease in aged mouse kidneys.Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease.Reactive oxygen species: influence on cerebral vascular tone.Heparan sulfate proteoglycans mediate Aβ-induced oxidative stress and hypercontractility in cultured vascular smooth muscle cellsVascular and Metabolic Factors in Alzheimer's Disease and Related Dementias: IntroductionPathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease.Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Abeta.Amyloid beta peptide 22-35 induces a negative inotropic effect on isolated rat hearts.Phospholipase A2 and arachidonic acid in Alzheimer's diseasePericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and diseaseRole of endothelial nitric oxide in cerebrovascular regulationNeuronal life span versus health span: principles of natural selection at work in the degenerating brain.The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseasesImaging of cerebrovascular pathology in animal models of Alzheimer's diseaseAβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes.
P2860
Q24646726-68F1CC5E-D5C3-413B-B1A4-7AF3619A11EBQ26771852-0F77DBAC-4DDC-4660-B34F-0B135B2E58B0Q26852369-541E1DEB-855A-452D-9022-A77BB3DFA156Q27006033-9037A646-1632-4748-821E-AE91B914043FQ28082612-D39B3212-A304-426B-904E-D9397B8115BDQ28389277-F821B3FC-5CB7-4EAA-8A6B-A1F53BC078B3Q28476620-FAA2D10C-D176-49D2-9A10-0E3587944AF5Q28594423-C2247559-D89E-4856-B4D1-53F33EDD174BQ30481236-A12AF181-E284-41C6-931C-655D87076A0AQ30597321-F0122110-CC89-4FD1-AA4F-F5F6C790CA6FQ30623665-E8AB2E65-372D-4D27-BD68-2DA0D9801046Q30666219-C25E3B87-68D7-4C54-99E2-BCB6E2088D16Q33201804-191FFCE0-3BE5-4077-A7B1-2060EB4ED659Q33588229-D6867053-F097-457E-A6DF-798E2BCFF824Q33863420-F3D2C29E-2E61-4B95-9393-CC556863CAECQ33967781-A8579AF1-F4BD-4B82-B582-DB6E27BD222BQ34297316-CFAF220C-3A58-4F09-93DA-E27144F36B58Q34455737-C9EE45F1-96A5-43E9-9E34-400EAACCDE54Q34828890-80547232-212C-411D-81D0-8189DD53F7E4Q34860664-1FBEA900-6A7E-4091-9315-CB77CBD25171Q35178724-7BCC40BA-D279-4028-8AEE-09632854DA0FQ35243119-89D7010D-4E55-4838-B3C0-AD920C83F5AAQ35639179-A77F9DB7-B1D1-45DF-A3BC-C1BB2DC05F3EQ35651255-44528333-641E-4C64-9A28-9E6893A876A2Q35753821-4E6B6F4F-FBE3-4242-B93A-932208373684Q35859758-C92BFF5F-F5EE-4838-8A88-F8CFD175D0BCQ36343094-D3335EA2-0D3A-4028-82C1-B696AB21418EQ36371878-6D2B092F-2C17-49D7-B07D-FFF4AB8F0D5DQ36489864-54F42114-F8B4-4E20-A18F-4A5C3607EBE9Q36840056-9081C1EF-C854-480B-B194-CCBE7F231527Q37169574-85F37426-4CE8-4075-9F9D-CDCBB6993BB8Q37257169-B9122267-84C6-4306-B407-D4193037DB67Q37553612-0D0EA9DD-C6A1-4B90-8BB3-05F2A50BC0A1Q37765687-3EC478BB-AD88-4FEF-9307-F074A5BB486DQ37781281-C00C8700-2049-40B4-9707-33B3506C8BBFQ37828563-0376327E-A951-43CF-B3C3-8E2092B3E129Q37874159-FDEE9407-73A8-48AC-83BB-5B3721D2646FQ38157892-1CC5EB87-11E9-4D2F-A08C-A6F803FCDADAQ38198632-05F0B6B0-1024-47E9-B9B3-52CFBAD5C065Q38259551-23349A52-26A2-445A-9E45-53450581DE41
P2860
A beta-peptides enhance vasoconstriction in cerebral circulation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A beta-peptides enhance vasoconstriction in cerebral circulation.
@ast
A beta-peptides enhance vasoconstriction in cerebral circulation.
@en
type
label
A beta-peptides enhance vasoconstriction in cerebral circulation.
@ast
A beta-peptides enhance vasoconstriction in cerebral circulation.
@en
prefLabel
A beta-peptides enhance vasoconstriction in cerebral circulation.
@ast
A beta-peptides enhance vasoconstriction in cerebral circulation.
@en
P2093
P2860
P1476
A beta-peptides enhance vasoconstriction in cerebral circulation.
@en
P2093
P2860
P304
P356
10.1152/AJPHEART.2001.281.6.H2417
P577
2001-12-01T00:00:00Z